Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel versus ropivacaine for pectoralis major intercostal plane block in median sternotomy
ChiCTR2400091199Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine and ropivacaine in acute pain (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Change in postoperative pain score within 24 hours. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2400091199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091199.